His lab is engaged on refining the alanine-scanning assay to a few essential residues that can properly distinguish among fibrils from neurodegenerative tauopathies. He envisions employing this streamlined assay for postmortem neuropathological prognosis, And maybe for blood screening of tauopathies.To start with, they analyzed this technique on 18